Full Text View
Tabular View
No Study Results Posted
Related Studies
Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
This study has been completed.
Study NCT00390312   Information provided by Javelin Pharmaceuticals
First Received: October 17, 2006   Last Updated: December 28, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Post-Operative Pain
Third Molar Extraction
Additional conditions recognized in this trial
Pain, Postoperative
More general conditions related to this trial
Pain
Pathologic Processes
Postoperative Complications
Signs and Symptoms
Interventions listed in this trial
Intranasal Placebo
Intranasal Morphine 15 mg
Intravenous morphine
Intranasal morphine 7.5 mg
Oral placebo
Intravenous placebo
Additional drug interventions recognized in this trial
Morphine
More general drug interventions related to this trial
Analgesics
Analgesics, Opioid
Central Nervous System Agents
Central Nervous System Depressants
Narcotics
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Javelin Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services